Financial Services
Live Price
Offline$13.26
-2.07% today
Window Change
-1.56%
Window
Jun 23, 2025 → Mar 27, 2026
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 193 bars · Jun 23, 2025 → Mar 27, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Nuveen S&P 500 Buy-Write Income Fund (BXMX) is a Financial Services stock with a market cap of $1.38B. The stock last traded around $13.26 and down 1.6% across the available one-year price window (Jun 23, 2025 → Mar 27, 2026). Baseline metrics include revenue growth of +113.9%, EPS growth of -9.5%, a dividend yield of 8.2%. What stands out right now is revenue +113.9%, EPS -9.5%, free cash flow 0.0% with operating margin 431.2% and ROIC 12.1%. The dividend matters to the case here, with a current yield around 8.2%. Valuation already assumes a fairly strong business story at P/E 6.6 and price/sales 28.5. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines BXMX price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
BXMX
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
BXMX Max Drawdown
-11.48%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for BXMX and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$250.1M
+63.2% YoY
FY Net Income
$249.2M
+235.5% YoY
Free Cash Flow
$0.0
Revenue Growth
+113.9%
EPS Growth
-9.5%
Gross Margin
34.7%
Net Margin
431.1%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 48M | 23M | 25M | 153M | 250M |
| Gross Profit | 35M | 23M | 242M | 141M | 237M |
| Operating Income | 209M | 9M | 241M | -184M | 249M |
| EBITDA | 209M | 0 | 241M | -194M | 245M |
| Net Income | 209M | 231M | 241M | -184M | 249M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 585 | 543 | 553 | 0 | 792 |
| Total Assets | 1.7B | 1.6B | 1.5B | 1.3B | 1.6B |
| Total Liabilities | 47M | 32M | 58M | 32M | 41M |
| Shareholder Equity | 1.7B | 1.6B | 1.5B | 1.3B | 1.6B |
| Total Debt | 25M | 22M | 27M | 7M | 2M |
| Net Debt | 25M | -543 | 27M | 7M | 2M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
0
Capital Expenditures
0
Free Cash Flow
0
Key ratios
Gross Margin
34.7%
Operating Margin
431.2%
Net Margin
431.1%
ROE
12.9%
Debt / Equity
0.01x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.